Trial Details

UNKNOWN
Basic Information
Clinical ID c584
Identifier NCT04882007
Trial Title Study of OSE-127 vs Placebo in Patients With Moderate to Severe Active Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Ulcerative Colitis
Interventions DRUG: OSE-127|DRUG: Placebo
Participant Information
Sponsor OSE Immunotherapeutics
City Brest
Country/Region Belarus
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2020-10-02
Primary Completion Date 2025-12-21
Completion Date 2025-03-23